Cargando…
The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
Although the precise mechanisms contributing to secondary brain injury following traumatic brain injury are complex and obscure, a number of studies have demonstrated that inflammatory responses are an obvious and early feature in the pathogenesis of traumatic brain injury. Inflammasomes are multipr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818859/ https://www.ncbi.nlm.nih.gov/pubmed/32788447 http://dx.doi.org/10.4103/1673-5374.286951 |
_version_ | 1783638925255901184 |
---|---|
author | Ismael, Saifudeen Ahmed, Heba A. Adris, Tusita Parveen, Kehkashan Thakor, Parth Ishrat, Tauheed |
author_facet | Ismael, Saifudeen Ahmed, Heba A. Adris, Tusita Parveen, Kehkashan Thakor, Parth Ishrat, Tauheed |
author_sort | Ismael, Saifudeen |
collection | PubMed |
description | Although the precise mechanisms contributing to secondary brain injury following traumatic brain injury are complex and obscure, a number of studies have demonstrated that inflammatory responses are an obvious and early feature in the pathogenesis of traumatic brain injury. Inflammasomes are multiprotein complexes that prompt the stimulation of caspase-1 and subsequently induce the maturation and secretion of proinflammatory cytokines, such as interleukin-1β and interleukin-18. These cytokines play a pivotal role in facilitating innate immune responses and inflammation. Among various inflammasome complexes, the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is the best characterized, a crucial role for NLRP3 has been demonstrated in various brain diseases, including traumatic brain injury. Several recent studies have revealed the contribution of NLRP3 inflammasome in identifying cellular damage and stimulating inflammatory responses to aseptic tissue injury after traumatic brain injury. Even more important, blocking or inhibiting the activation of the NLRP3 inflammasome may have substantial potential to salvage tissue damage during traumatic brain injury. In this review, we summarize recently described mechanisms that are involved in the activation and regulation of the NLRP3 inflammasome. Moreover, we review the recent investigations on the contribution of the NLRP3 inflammasome in the pathophysiology of TBI, and current advances and challenges in potential NLRP3-targeted therapies. A significant contribution of NLRP3 inflammasome activation to traumatic brain injury implies that therapeutic approaches focused on targeting specific inflammasome components could significantly improve the traumatic brain injury outcomes. |
format | Online Article Text |
id | pubmed-7818859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-78188592021-01-22 The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury Ismael, Saifudeen Ahmed, Heba A. Adris, Tusita Parveen, Kehkashan Thakor, Parth Ishrat, Tauheed Neural Regen Res Review Although the precise mechanisms contributing to secondary brain injury following traumatic brain injury are complex and obscure, a number of studies have demonstrated that inflammatory responses are an obvious and early feature in the pathogenesis of traumatic brain injury. Inflammasomes are multiprotein complexes that prompt the stimulation of caspase-1 and subsequently induce the maturation and secretion of proinflammatory cytokines, such as interleukin-1β and interleukin-18. These cytokines play a pivotal role in facilitating innate immune responses and inflammation. Among various inflammasome complexes, the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is the best characterized, a crucial role for NLRP3 has been demonstrated in various brain diseases, including traumatic brain injury. Several recent studies have revealed the contribution of NLRP3 inflammasome in identifying cellular damage and stimulating inflammatory responses to aseptic tissue injury after traumatic brain injury. Even more important, blocking or inhibiting the activation of the NLRP3 inflammasome may have substantial potential to salvage tissue damage during traumatic brain injury. In this review, we summarize recently described mechanisms that are involved in the activation and regulation of the NLRP3 inflammasome. Moreover, we review the recent investigations on the contribution of the NLRP3 inflammasome in the pathophysiology of TBI, and current advances and challenges in potential NLRP3-targeted therapies. A significant contribution of NLRP3 inflammasome activation to traumatic brain injury implies that therapeutic approaches focused on targeting specific inflammasome components could significantly improve the traumatic brain injury outcomes. Wolters Kluwer - Medknow 2020-08-10 /pmc/articles/PMC7818859/ /pubmed/32788447 http://dx.doi.org/10.4103/1673-5374.286951 Text en Copyright: © 2021 Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Ismael, Saifudeen Ahmed, Heba A. Adris, Tusita Parveen, Kehkashan Thakor, Parth Ishrat, Tauheed The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury |
title | The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury |
title_full | The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury |
title_fullStr | The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury |
title_full_unstemmed | The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury |
title_short | The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury |
title_sort | nlrp3 inflammasome: a potential therapeutic target for traumatic brain injury |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818859/ https://www.ncbi.nlm.nih.gov/pubmed/32788447 http://dx.doi.org/10.4103/1673-5374.286951 |
work_keys_str_mv | AT ismaelsaifudeen thenlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT ahmedhebaa thenlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT adristusita thenlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT parveenkehkashan thenlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT thakorparth thenlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT ishrattauheed thenlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT ismaelsaifudeen nlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT ahmedhebaa nlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT adristusita nlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT parveenkehkashan nlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT thakorparth nlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury AT ishrattauheed nlrp3inflammasomeapotentialtherapeutictargetfortraumaticbraininjury |